About DNADVENTLifesciences
DNADVENTLifesciences is a company based in Hyderabad (India) founded in 2016. It operates as a B2B. DNADVENTLifesciences operates in a competitive market with competitors including Foundation Medicine, MedGenome, Burning Rock, Zhejiang Nuhui Health Technology and 3billion, among others.
- Headquarter Hyderabad, India
- SectorsHealthcare
- Website dnadvent.com
- Social X
- Legal Name Dnadvent Lifesciences Private Limited
- Date of Incorporation 16 Dec, 2016
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹33.8 Lakh
FY 2024 · +42% YoY
- Net Profit₹2.4 Lakh
FY 2024 · 7% margin
- EBITDA₹3.6 Lakh
FY 2024 · 11% margin
Associated legal entities of DNADVENTLifesciences
DNADVENTLifesciences operates through Dnadvent Lifesciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Dnadvent Lifesciences Private Limited CIN U85300TG2016PTC113450 | Active | 16 Dec 2016 | Hyderabad, Telangana | ₹0.3 Cr | – | 4 | View details |
Board of directors of Dnadvent Lifesciences Private Limited (DNADVENTLifesciences)
Dnadvent Lifesciences Private Limited is the primary company behind DNADVENTLifesciences. The board of Dnadvent Lifesciences Private Limited currently have 4 directors; the longest-serving is Kousthubh Kumar Thatipamula, appointed in 2016. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Kousthubh Kumar Thatipamula DIN 07669369 | Director | 16 Dec 2016 | 9 yrs 9 mo | Dnadvent Lifesciences Private Limited |
| Parre Basava Rao DIN 07669374 | Director | 16 Dec 2016 | 9 yrs 9 mo | Dnadvent Lifesciences Private Limited |
| Karthik Kumar Tatipamula DIN 07674332 | Director | 16 Dec 2016 | 9 yrs 9 mo | Dnadvent Lifesciences Private Limited |
| Krishna Chary Nagaram DIN 07669378 | Director | 27 Jul 2017 | 9 yrs 2 mo | Dnadvent Lifesciences Private Limited |
Financials of DNADVENTLifesciences
Figures of Dnadvent Lifesciences Private Limited, the primary company behind DNADVENTLifesciences, for FY 2024. Revenue was ₹33.8 Lakh (+42% year on year). Net profit was ₹2.4 Lakh (7% margin). EBITDA was ₹3.6 Lakh (11% margin). Revenue has grown at a compounded annual rate of -12% over three years and +3% over five years.
- ₹33.8 LakhRevenue · FY 2024 · +42% YoY
- ₹2.4 LakhNet profit · 7% margin
- ₹3.6 LakhEBITDA · 11% margin
- ₹1.4 LakhPaid-up capital
- -12%Revenue CAGR, 3 years
- +3%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Dnadvent Lifesciences Private Limited are on its company page.
Detailed financial statements for DNADVENTLifesciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of DNADVENTLifesciences
DNADVENTLifesciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Foundation Medicine, MedGenome, Burning Rock, Zhejiang Nuhui Health Technology and 3billion, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| foundationmedicine.com | 2010 | Cambridge, United States | $96.5M | 1,707 | Genomics-based diagnostic tests for cancer are provided. | |
| medgenome.com | 2013 | Bengaluru, India | $264.5M | 922 | DNA sequencing, bioinformatics, and multiomics services are provided. | |
| brbiotech.com | 2014 | Guangzhou, China | $203.32M | – | Personalized cancer diagnostics are developed using genomic big data analysis. | |
| newhorizonbio.com | 2013 | Beijing, China | $151.83M | – | Provider of early cancer screening and testing services | |
| 3billion.io | 2016 | Seoul, South Korea | $25.69M | – | AI-driven diagnostic platform for rare genetic diseases is offered. | |
| baebies.com | 2013 | Durham, United States | $95.89M | 133 | Provider of diagnostic products for pediatrics | |
| nimgenetics.com | 2007 | Madrid, Spain | $7.63M | – | Diagnostic solutions are developed using microarray and next-generation sequencing technologies. | |
| crisprbits.com | 2020 | Delhi, India | $446,670 | – | CRISPR-based diagnostic tests for diseases are developed. | |
| nextcode.com | 2013 | Cambridge, United States | $15M | – | Genomics platform for clinical insights and rapid diagnoses is provided. |
Detailed competitors of DNADVENTLifesciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to DNADVENTLifesciences
10 companies that operate in the same segment as DNADVENTLifesciences (Clinical Genomics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
Panomic profiling technologies are developed for cancer precision medicine. | 1996 | Irving, Texas, United States | USD 1.23 B | – | 1,339 | |
Genomics-based diagnostic tests for cancer are provided. | 2010 | Cambridge, Massachusetts, United States | USD 96.5 M | – | – | |
Digital molecular biology analytics are developed for disease management. | 2012 | Carlsbad, California, United States | USD 95.02 M | – | 46 | |
Diagnostic tests for cancer prognosis are provided. | 2008 | Friendswood, Texas, United States | USD 61.97 M | USD 344.23 M | 761 | |
Genomic database for clinical research is provided. | 2015 | San Francisco, California, United States | USD 435 M | – | – | |
Genomic sequencing and diagnosis software is provided for healthcare. | 2011 | Menlo Park, California, United States | USD 87.3 M | USD 69.65 M | 229 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about DNADVENTLifesciences
DNADVENTLifesciences was founded in 2016.
DNADVENTLifesciences is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
The primary company behind DNADVENTLifesciences, Dnadvent Lifesciences Private Limited, reported revenue of ₹33.8 Lakh for FY 2024, up 42% year on year.
DNADVENTLifesciences operates with a B2B model, focusing on providing healthcare solutions, advancing biotech innovations, focusing on genomic solutions, and neonatal diagnostics. Offers comprehensive genomic-based diagnostic tests for newborn babies. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
DNADVENTLifesciences's top competitors include Foundation Medicine, MedGenome and Baebies.
DNADVENTLifesciences operates through Dnadvent Lifesciences Private Limited.
The legal entities of DNADVENTLifesciences currently have 4 directors, including Kousthubh Kumar Thatipamula, Parre Basava Rao, Karthik Kumar Tatipamula and others.